EXAM 2 - FULL REVIEW Flashcards
Autonomic nervous system
Systems not under conscious control, sympathetic/parasympathetic nervous system and enteric (gut with neurons?)
Sympathetic responses
increased HR/BP, dilated bronchioles, shunting to needed muscles. fight or flight bruh
Parasympathetic response
Rest and digest, conserve energy, shunt blood to endocrine, gi, urogenital.
Function of chain ganglia, and how they are similar to PNS plexi
sympathetic chain ganglia run along sides of spinal cord and transmit information for the sympathetic response.
PNS plexi help distribute parasympathetic response to specific organs
Sympathetic NS response, NTs, receptors, anatomy
originates from thoracolumbar region of spinal cord, short preganglionic fibers that release ach and long postganglionic fibers that release NE.
Uses receptors A1/2, b1/2/3
Paraympathetic NS response, NTs, receptors, anatomy
slow HR, promote digestion. Uses ach at both pre and post ganglionic neurons. Uses muscarinic and nicotinic receptors, and have long preganglionic fibers and short postganglionic fibers.
Sympathomimetic
drugs that mimic effect of sympathetic ns (epi)
Parasympathomimetics
drugs that mimic parasympathetic ns (acetyhlcholine)
Parasympathoplegic
drugs that inhibit parasympathetic (atropine)
Sympathoplegic
Drug that inhibit sympathetic ns (alpha and beta blockers)
Adrenergic (gQ, gI, gS) and their effects
alpha 1/2 and beta 1/2.
-Alpha 1 is gQ, and increases phospholipase C -> IG3/DAG
-Alpha 2 is gI, and decreases cAMP
-Beta1/2/3 are gS, increase cAMP
Cholinergic receptors
nicotinic: ligand-gated ion channels
muscarinic: g-protein coupled, varying subtypes (m1, m2, etc.
M1, 3 and 5 are excitatory (phospholipase C, gQ)
m2 and m4 are inhibitory, related to gI proteins to decrease cAMP
Where are alpha and beta receptors found? muscarinic and nicotinic?
alpha1 - blood vessels and eyes
alpha 2 - nervous system
beta-1 - heart
beta2-lungs and skeletal muscles (dilation for each)
muscarinic - heart and smooth muscle, glands
nicotinic - skeletal muscles and brain
6 classes of NTs and example
Esters - ACH
Monoamines - NE, serotonin, dopamine
Amino Acids - Glutamate, GABA
Purines - Adenosine, ATP
Peptides - Substance P, endorphins
Inorganic Gases - Nitric Oxide (NO)
Types of synpases
Electrical juntion, chemical synapse, and axodendritic synapse
Fate of NTs in synapse
Reuptake into neuron, degraded by enzymes, and diffusion
NE transport, storage, release and degradation
Synthesized from tyrosine into cell by CHT, combined by CHAT and stored in vesicles via VAT, and either taken back into presynaptic cell or degraded by monoamine oxidase (MAO)
Major uses of cholinomimetic agonists include
glaucoma (pilocarpine), urinary retention (bethanechol), diagnostic tool for MG (edrophonium)
Pharmacodynamic differences between direct acting and indirect acting cholinomimetic agents
direct acting bind directly to receptor to produce effects while indirect acting will inhibit things such as acetylcholinesterase to have more effect.
Difference between nicotinic and muscarinic
nicotinic are ionotropic and found at NMJ and autonomic ganglia, super fast
muscarinic are GPCRs found in heart and smooth muscles, glands, mediate slower and longer lasting effects.
Cholinomimetics effects in major organ systems
miosis and decreased intraocular prssure, decreased heart rate/contractility, increased GI motility/secretion, and increased bladder contraction
Types of glaucoma and drugs
open angle: increased intraocular pressure due to improper drainage, treated with pilocarpine to increase aqeuous outflow
closed angle: sudden blockage of drainage, acute pressure increase, emergency treatment
s/s of organophoshate poisoning
SLUDGE-M, resp failure, bradycardia.
s/s nictonic toxicity
N/V, muscle twitching, seizures/coma
effects on atropine across different organs
eyes: mydriasis and cycloplegia (dilation, dry eyes)
GI: decreases motility/secretions
Resp: reduces bronchial secretions
s/s atropine overdose and treatment
Dry mouth, blurred vision, tachycardia, hallucinations, hyperthermia (reduced sweating)
treatment: cholinesterase inhibitors such as physostigmine to reverse effects.
use of cholinomimetics in disease
MG (edrophonium to diagnose, stigmine to treat)
Glaucoma: pilocarpine
postop ileus: bethanechol to increase GI motility
clinical indications and contraindications for muscarinic antagonist
indications: bradycardia, motion sickness, reduce secretions for surgery
contraindications: glaucoma, urinary retention, obstructive GI diseases
Effects of two types of nicotinic antagonists
Ganglionic blockers and neuromuscular blockers
two types of muscle relaxants
depolarizing agents (sux) and non depolarizing agents (rocuronium)
catecholamine structure
consist of a benzene ring with hydroxyl groups at 3 and 4 position and amine group on the side chain. Removing hydroxyl groups (COMT), and MAO.
e.g. ephedrine is not degraded by these enzymes due to absence of OH groups
MOA of direct and indirect acting catecholamines
direct acting: (norepi and epi) bind directly to adrenergic receptors.
indirect-acting: (amphetamines) increase release or block reuptake of NE leading to prolonged affects
alpha-agonist, beta agonist, mixed agonist
alpha: phenylephrine - vasoconstrction, increased peripheral resistance, blood pressure
beta: isoproterenol - hr and contractility, reducing peripheral resistance.
mixed: epi - increase HR, contractility, vasoconstriction, increased BP
Nonselective alpha agonist
selective alpha 2
nonselective beta agonist
selective beta-1 agonist
selective beta 2 agonist
- epi
- clonidine
- isoproterenol
- dobutamine
- albuterol
tissues with alpa 1 and alpha 2 receptors
alpha 1 - blood vessels
alpha 2 - CNS and presynaptic nerve terminals
Tissues containing beta 1/2 receptors
beta 1 - heart
beta 2 - lungs
Major clinical applications of adrenoceptor agonists include
epi for anaphylaxis/cardiac arrest
dobutamine for heart failure
albuterol for asthma
phenylephrine for nasal decongestion/hypotension
triphasic effects of dopamine
low dose: D1 receptors, vasodilation in kidneys
mid dose: B1 contractility and hr
high dose: A1 vasoconstriction
common toxicities with sympathomimetics
CV toxicity: arrythmias, hypertension
CNS toxicity: anxiety, tremors, seizures
OTher: hyperglycemia, hypokalemia
Describe and compare the effects of an alpha blocker on BP/HR
cause vasodilation by inhibiting a1 receptors, reducing vascular resistance and lowering BP.
May lead to reflex tachycardia.
Effects of alpha blocker in presence/absence of agonist
absence: there is nothing to block and has little to not effect
presence (in presence of epi): prevents epi effects i.e. vasoconstriction Hr/contractility, may cause reflex tachycardia.
list the alpha and beta blockers described in class and their clinical uses
Alpha:
Phentolamine - used in pheochromocytoma and hypertensive emergencies
prazosin - used for hypertension and BPH
Beta:
propanolol - non selective, for htn, angina, arrythmias
metoprolol - beta 1 selective, used for heart failure and hypertension (not in end stage HF, need contractility)
labetalol - mixed alpha/beta, used in hypertensive crises
explain this sentence: phentolamine converts a pressor into a depressor
phentolamine is a competitive alpha blocker and it inhibits effects of epi on alpha receptors. By blocking these receptors, epi effects shift to beta-2 receptor mediated vasodilation, leading to a decrease in BP instead of increase.
Define the difference between selective and non selective beta blockers
selective beta blockers primarily block beta-1 receptors, which are found int he heart
non-selective beta blockers block both beta1 and 2, affecting heart rate as well as lungs causing bronchoconstriction (propanolol)
clinical indications and toxicities of beta blockers
indication: htn, angina, hf, arrythmias
toxicities: bradycardia, fatigue, bronchoconstriction, worsening of peripheral vascular disease.
clinical indications and toxicities of alpha blockers
indication: hypertension, BPH and pheochromocytoma
toxicity: orthostatic hypotension, reflex tachycardia.
regulators of BP
cardiac output (SV x HR) and PVR which is influenced by blood viscosity, vessel diameter, and vessel length.
anatomic control sites for BP
Heart (CO), blood vessels (PVR), kidneys (fluid balance, RAAS), and CNS (symp vs parasymp)
Non-pharmacological interventions for elevated BP
Dietary changes (DASH diet, reduced sodium intake)
Weight loss
physical activity
stress management
reduction of alcohol intake
Major groups of antihypertensive medications
diuretics (hydrochlorothiazide, furosemide, spironolactone)
beta blockers (metoprolol, propanolol)
calcium channel blockers (diltiazem, amlodipine, verapamil)
ACE inhibitors (lisinopril)
Renin inhibitors (aliskiren only one)
ARBs (losartan, valsartan)
Targets of centrally acting sympathoplegics
clonidine and methyldopa act on a2 receptors in CNS, specifically medulla oblongata, to reduce sympathetic outflow, lower BP, and decrease peripheral resistance.
major sites of action of peripheral sympathoplegics
beta receptors in heart (propanolol) and alpha 1 receptors (Prazosin)
doses for metoprolol, atenolol, and esmolol
metoprolol: 50-100mg/day (oral)
atenolol: 25-100mg/day (oral)
Esmolol: 50-300mcg/kg/min (IV infusion)
mechanism of action of vasodilator drugs and 4 classifications
work by relaxing vascular smooth muscle to reduce PVR
direct-acting vasodilators (hydralizine)
calcium channel blocker (amlodipine)
nitrates (nitoglycerin)
potassium channel openers (minoxidil)
compensatory response to vasodilators
tachycardia due to baroreceptor reflex and fluid retention due to RAAS
Major antihypertensive vasodilator drug and effects
Hydralazine (arterial dialation)
Minoxidil (Arteriolar dilation)
Sodium nitroprusside (arterial and venous dilation, used in hypertensive EMERGENCIES)
concerns with sodium nitroprusside and dosing
used in htn emergencies but may cause cyanide toxicity with prolonged use. 0.3-10mcg/kg/min
three classes of CBBs and major target
Dihydropyridines (peripheral vasculature, amlodipine)
Phenylalkylamines (Heart, verapamil)
Benzothiazepines (mixed heart/vessel, diltiazem)
RAAS pathway and treatment targets
Renin converts angiotensin to angiotensin I, ACE converts angiotensin I to angiotensin II, which increases BP by vasoconstriction and aldosterone release. Treatment targets ACE inhibitors such as lisinopril and ARBs (losartan)
There is one Renin inhibitor, called aliskiren
Differences between 2 angiotensin antagonists
ACE-I: block the conversion of angiotensin I to angiotensin II. (lisinopril)
ARBs: Block angiotensin II receptors (losartan)
MOA for pulm hypertension therapeutics
Prostacyclin analogs (epoprostenol), endothelin receptor antagonist (bosentan) and PDE-5 inhibitors (sildenafil)
Hypertensive urgency and hypertensive crisis (emergency)
Urgency: >180/100, no end organ damage (fix in hours to days)
Emergency: >180/110, with end organ damage, this is an emergency. (fix immediately)
Treatments for mild/mod/severe hypertension
mild: lifestyle mods and monotherapy
moderate: combination of two drugs (beta blocker + diuretic)
Severe/emergent: IV antihypertensives (sodium nitroprusside, cardene)
Differences in arterial, capillary, and venous tone
Arterial tone: controls BP
Venous: influences venous return and preload
Capillary: can completely shunt to bypass blood and make it go to more important parts of body.
Pathophysiology of effort angina and vasospastic angina
Effort: occurs with physical activity due to increased myocardial demand
Vasospastic: occurs at rest due to coronary artery spasm, determinants of oxygen consumption include HR, contractility and wall tension.
Coronary blood flow and diastole
directly related to duration of diastole because thats when the coronary arteries fill with blood.
Strategies for anginal pain relief
Drugs reducing oxygen demand such as beta blockers and nitrates, and increase oxygen supply (calcium channel blockers)
molecular pathways of vascular tone and drug targets
Pathways include nitric oxide, calcium, cAMP/cGMP, with targets like CCBs and nitrates.
Primary nitrates and nitrites
Nitroglycerin, isosorbide dinitrate, isosorbide mononitrate
they cause vasodilation by increasing cGMP, used in angina and HF
Concerns with nitrate overexposure
Tolerance and methemoglobinemia (reduced oxygen binding) are major concerns with prolonged use of nitrates
Receptor differences in epicardial arteries
Alpha receptors cause vasoconstriction (reducing blood flow to heart and increasing BP, and beta 1 receptors cause increased heart rate and contractility.
Beta-2 receptors in the smaller vasculature of the heart can dilate smaller arterioles and increase blood flow to heart.
Targets of pFOX inhibitors and what drug?
Target fatty acid oxidation to reduce oxygen consumption in ischemic heart disease.
Drug is called Ranolazine and it acts on sodium channels to improve myocardial relaxation, not available in the US currently.